Swissmedic reviewing AstraZeneca’s COVID-19 vaccine

SwissInfo

6 October 2020 - Swiss drug authority Swissmedic has begun evaluating the so-called “Covid-19 Vaccine AstraZeneca”. 

It is the first time that a drug maker has presented a coronavirus vaccine for approval in Switzerland.

Read SwissInfo article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Vaccine , Dossier , Switzerland , COVID-19